Pediatric Case Series of Cystic Fibrosis, Diabetes, and Islet Cell Autoimmunity
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Mastracci T, Apte M, Amundadottir L, Alvarsson A, Artandi S, Bellin M Diabetes. 2023; 72(4):433-448.
PMID: 36940317 PMC: 10033248. DOI: 10.2337/db22-0942.
References
1.
Moran A, Pillay K, Becker D, Acerini C
. ISPAD Clinical Practice Consensus Guidelines 2014. Management of cystic fibrosis-related diabetes in children and adolescents. Pediatr Diabetes. 2014; 15 Suppl 20:65-76.
DOI: 10.1111/pedi.12178.
View
2.
Gottlieb P, Yu L, Babu S, Wenzlau J, Bellin M, Frohnert B
. No relation between cystic fibrosis-related diabetes and type 1 diabetes autoimmunity. Diabetes Care. 2012; 35(8):e57.
PMC: 3402258.
DOI: 10.2337/dc11-2327.
View
3.
Konrad K, Kapellen T, Lilienthal E, Prinz N, Bauer M, Thon A
. Does β-Cell Autoimmunity Play a Role in Cystic Fibrosis-Related Diabetes? Analysis Based on the German/Austrian Diabetes Patienten Verlaufsdokumentation Registry. Diabetes Care. 2016; 39(8):1338-44.
DOI: 10.2337/dc16-0020.
View
4.
Wenzlau J, Juhl K, Yu L, Moua O, Sarkar S, Gottlieb P
. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A. 2007; 104(43):17040-5.
PMC: 2040407.
DOI: 10.1073/pnas.0705894104.
View
5.
Hameed S, Jaffe A, Verge C
. Cystic fibrosis related diabetes (CFRD)--the end stage of progressive insulin deficiency. Pediatr Pulmonol. 2011; 46(8):747-60.
DOI: 10.1002/ppul.21495.
View